Bovaclox DC Intramammary Suspension

Land: Ierland

Taal: Engels

Bron: HPRA (Health Products Regulatory Authority)

Werkstoffen:

Cloxacillin Benzathine; Ampicillin trihydrate

Beschikbaar vanaf:

Norbrook Laboratories (Ireland) Limited

ATC-code:

QJ51RC

INN (Algemene Internationale Benaming):

Cloxacillin Benzathine; Ampicillin trihydrate

Dosering:

500, 250 mg/syringe

farmaceutische vorm:

Intramammary suspension

Prescription-type:

POM: Prescription Only Medicine as defined in relevant national legislation

Therapeutisch gebied:

Beta-lactam antibacterials, penicillins, combinations with other antibacterials

Autorisatie-status:

Authorised

Autorisatie datum:

1987-10-01

Productkenmerken

Health Products Regulatory Authority
25 January 2019
CRN008SVL
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Bovaclox DC Intramammary Suspension
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 4.5 g syringe contains:
Cloxacillin (as Cloxacillin Benzathine) 500 mg and Ampicillin (as
Ampicillin Trihydrate)
250 mg.
For a full list of excipients see section 6.1.
3 PHARMACEUTICAL FORM
Intramammary suspension. An off-white suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Dairy cattle.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For routine use in the dairy cow at the point of drying off, that is
immediately after
the last milking of the lactation in order to treat existing mastitis
and to provide
protection against further infections during the dry period. It also
aids in reducing
the incidence of summer mastitis in dry cows at risk. Bovaclox DC is
active against:
_Streptococcus _spp_._
_Staphylococcus _spp_._
_Corynebacterium _spp_. _
4.3 CONTRAINDICATIONS
Not to be used in lactating cows.
Do not use within 45 days of calving.
Do not use in cows known to be hypersensitive to the active
ingredients.
Health Products Regulatory Authority
25 January 2019
CRN008SVL
Page 2 of 6
4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES
In the event of accidental treatment of lactating cows, the milk
should be discarded
for 30 days following which time the milk should be tested until
antibiotics can no
longer be detected.
4.5 SPECIAL PRECAUTIONS FOR USE
SPECIAL PRECAUTION(S) FOR USE IN ANIMALS
When infusing cows it is important that the syringe nozzle is not
introduced into the
teat. The animal should be properly restrained. The teats are cleaned
and disinfected.
The teat orifice is located and the nozzle of the syringe placed
against it but NOT
inserted. When the syringe plunger is depressed the antibiotic passes
easily through
the teat orifice into the udder.
SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
MEDICINAL
PRODUCT TO ANIMALS
Penicillin and cephalospori